Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

HTG Molecular Diagnostics to Announce Second Quarter and Six Months Ended June 30, 2018 Financial Results and Host Conference Call on Tuesday, August 7

Posted on: 24 Jul 18

TUCSON, Ariz., July 24, 2018 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq:HTGM), a provider of instruments, reagents, and services for molecular profiling applications, today announced that it will report its financial results for the three and six months ended June 30, 2018 after the market close on Tuesday, August 7.  Management will also host a conference call with investors to discuss financial results and provide a corporate update at 4:30pm Eastern Time.

Conference Call & Webcast Details 
Date:Tuesday, August 7
Time: 4:30pm Eastern Time
Toll Free:866-575-6539
Conference ID:5460628

About HTG:
HTG is focused on next generation sequencing (NGS) based molecular profiling. The company’s proprietary HTG EdgeSeq technology automates complex, highly multiplexed molecular profiling from solid and liquid samples, even when limited in amount. HTG’s customers use its technology to identify biomarkers important for precision medicine, to understand the clinical relevance of these discoveries, and ultimately to identify treatment options. Our mission is to empower precision medicine at the local level.

Ashley Robinson
LifeSci Advisors, LLC

TJ Johnson
Chief Executive Officer
HTG Molecular Diagnostics
520-547-2827 x130



Last updated on: 24/07/2018

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.